Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Hospira history
Hospira company history timeline
In 2007, Hospira purchased Mayne Pharma Ltd., an Australian-based specialty injectable pharmaceuticals company, for $2.1 billion.
Begley had announced his retirement as Hospira's chief executive in August 2010, but had remained as executive chairman.
In 2010, Hospira acquired Javelin Pharmaceuticals, Inc., maker of post-operative pain management drug Dyloject, for approximately $145 million.
In 2011, Hospira's board chose Mike Ball, formerly president of Allergan, as Hospira's new CEO. Ball became CEO in March 2011.
Hospira named John Staley its non-executive chairman with the retirement of former executive chairman Christopher Begley in January 2012.
The roughly $17 billion acquisition was completed in September, 2015.
Rate how well Hospira lives up to its initial vision.
Hospira jobs
Do you work at Hospira?
Is Hospira's vision a big part of strategic planning?
Hospira competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Johnson & Johnson | 1886 | $88.8B | 134,500 | 1,852 |
| Merck | 1891 | $64.2B | 74,000 | 1,368 |
| Nektar Therapeutics | 1990 | $98.4M | 718 | - |
| Baxter International | 1931 | $10.6B | 48,000 | 202 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 740 |
| Seagen | 1997 | $2.0B | 900 | - |
| Regeneron | 1988 | $14.2B | 9,123 | 352 |
| Amgen | 1980 | $33.4B | 22,000 | 638 |
| Axygen | 1993 | $240,000 | 200 | - |
| Haemonetics | 1971 | $1.3B | 3,300 | 194 |
Hospira history FAQs
Zippia gives an in-depth look into the details of Hospira, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Hospira. The employee data is based on information from people who have self-reported their past or current employments at Hospira. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Hospira. The data presented on this page does not represent the view of Hospira and its employees or that of Zippia.
Hospira may also be known as or be related to HOSPIRA INC, Hospira, Hospira Inc, Hospira Inc. and Hospira, Inc.